Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 31 entries
Sorted by: Best Match Show Resources per page
Drug product quality--views of the practitioners. A physician's perception of quality.

Journal of the American Pharmaceutical Association

Perloff MM.
PMID: 977887
J Am Pharm Assoc. 1976 Nov;16(11):608-9. doi: 10.1016/s0003-0465(16)33784-3.

No abstract available.

Cite
Perloff MM. Drug product quality--views of the practitioners. A physician's perception of quality. J Am Pharm Assoc. 1976;16(11):608-9doi: 10.1016/s0003-0465(16)33784-3.
Perloff, M. M. (1976). Drug product quality--views of the practitioners. A physician's perception of quality. Journal of the American Pharmaceutical Association, 16(11), 608-9. https://doi.org/10.1016/s0003-0465(16)33784-3
Perloff, M M. "Drug product quality--views of the practitioners. A physician's perception of quality." Journal of the American Pharmaceutical Association vol. 16,11 (1976): 608-9. doi: https://doi.org/10.1016/s0003-0465(16)33784-3
Perloff MM. Drug product quality--views of the practitioners. A physician's perception of quality. J Am Pharm Assoc. 1976 Nov;16(11):608-9. doi: 10.1016/s0003-0465(16)33784-3. PMID: 977887.
Copy Download .nbib Format: NLM
[Drug safety. Introduction to the topic].

Der Internist

Dölle W, Sewing KF.
PMID: 352980
Internist (Berl). 1978 Jun;19(6):325.

No abstract available.

Cite
Dölle W, Sewing KF. Arzneimittelsicherheit. Einführung zum Thema. [Drug safety. Introduction to the topic]. Internist (Berl). 1978;19(6):325
Dölle, W., & Sewing, K. F. (1978). Arzneimittelsicherheit. Einführung zum Thema. [Drug safety. Introduction to the topic]. Der Internist, 19(6), 325.
Dölle, W, and Sewing, K F. "Arzneimittelsicherheit. Einführung zum Thema." [Drug safety. Introduction to the topic]. Der Internist vol. 19,6 (1978): 325.
Dölle W, Sewing KF. Arzneimittelsicherheit. Einführung zum Thema. [Drug safety. Introduction to the topic]. Internist (Berl). 1978 Jun;19(6):325. German. PMID: 352980.
Copy Download .nbib Format: NLM
A vexed question.

JAMA

[No authors listed]
PMID: 5820377
JAMA. 1969 Oct 06;210(1):128.

No abstract available.

Cite
A vexed question. JAMA. 1969;210(1):128
(1969). A vexed question. JAMA, 210(1), 128.
"A vexed question." JAMA vol. 210,1 (1969): 128.
A vexed question. JAMA. 1969 Oct 06;210(1):128. PMID: 5820377.
Copy Download .nbib Format: NLM
Quality assurance of raw materials.

Medical services journal, Canada

Jenkins JW.
PMID: 6056370
Med Serv J Can. 1967 Mar;23(3):252-61.

No abstract available.

Cite
Jenkins JW. Quality assurance of raw materials. Med Serv J Can. 1967;23(3):252-61
Jenkins, J. W. (1967). Quality assurance of raw materials. Medical services journal, Canada, 23(3), 252-61.
Jenkins, J W. "Quality assurance of raw materials." Medical services journal, Canada vol. 23,3 (1967): 252-61.
Jenkins JW. Quality assurance of raw materials. Med Serv J Can. 1967 Mar;23(3):252-61. PMID: 6056370.
Copy Download .nbib Format: NLM
Report on drugs, miscellaneous.

Journal - Association of Official Analytical Chemists

Hopes TM.
PMID: 4816483
J Assoc Off Anal Chem. 1974 Mar;57(2):255-7.

No abstract available.

Cite
Hopes TM. Report on drugs, miscellaneous. J Assoc Off Anal Chem. 1974;57(2):255-7
Hopes, T. M. (1974). Report on drugs, miscellaneous. Journal - Association of Official Analytical Chemists, 57(2), 255-7.
Hopes, T M. "Report on drugs, miscellaneous." Journal - Association of Official Analytical Chemists vol. 57,2 (1974): 255-7.
Hopes TM. Report on drugs, miscellaneous. J Assoc Off Anal Chem. 1974 Mar;57(2):255-7. PMID: 4816483.
Copy Download .nbib Format: NLM
[The testing of new drugs].

Ceskoslovenska farmacie

Geryser L.
PMID: 6076699
Cesk Farm. 1967 Oct;16(8):421.

No abstract available.

Cite
Geryser L. Zkousení nových léciv. [The testing of new drugs]. Cesk Farm. 1967;16(8):421
Geryser, L. (1967). Zkousení nových léciv. [The testing of new drugs]. Ceskoslovenska farmacie, 16(8), 421.
Geryser, L. "Zkousení nových léciv." [The testing of new drugs]. Ceskoslovenska farmacie vol. 16,8 (1967): 421.
Geryser L. Zkousení nových léciv. [The testing of new drugs]. Cesk Farm. 1967 Oct;16(8):421. Czech. PMID: 6076699.
Copy Download .nbib Format: NLM
A bleak future for new drugs and devices.

Tennessee nurse

Porterfield L.
PMID: 8399262
Tenn Nurse. 1993;56(2):9.

No abstract available.

Cite
Porterfield L. A bleak future for new drugs and devices. Tenn Nurse. 1993;56(2):9
Porterfield, L. (1993). A bleak future for new drugs and devices. Tennessee nurse, 56(2), 9.
Porterfield, L. "A bleak future for new drugs and devices." Tennessee nurse vol. 56,2 (1993): 9.
Porterfield L. A bleak future for new drugs and devices. Tenn Nurse. 1993;56(2):9. PMID: 8399262.
Copy Download .nbib Format: NLM
[Quantitative methods of pharmacotherapeutical evaluation of drugs--evaluation, planning, screening].

Biometrische Zeitschrift

Brock N, Schneider B.
PMID: 5183162
Biom Z. 1966;8(3):147-61. doi: 10.1002/bimj.19660080302.

No abstract available.

Cite
Brock N, Schneider B. Quantitative Methoden bei der pharmakotherapeutischen Bewertung von Arzneimitteln--Auswertung, Planung, Screening. [Quantitative methods of pharmacotherapeutical evaluation of drugs--evaluation, planning, screening]. Biom Z. 1966;8(3):147-61doi: 10.1002/bimj.19660080302.
Brock, N., & Schneider, B. (1966). Quantitative Methoden bei der pharmakotherapeutischen Bewertung von Arzneimitteln--Auswertung, Planung, Screening. [Quantitative methods of pharmacotherapeutical evaluation of drugs--evaluation, planning, screening]. Biometrische Zeitschrift, 8(3), 147-61. https://doi.org/10.1002/bimj.19660080302
Brock, N, and Schneider, B. "Quantitative Methoden bei der pharmakotherapeutischen Bewertung von Arzneimitteln--Auswertung, Planung, Screening." [Quantitative methods of pharmacotherapeutical evaluation of drugs--evaluation, planning, screening]. Biometrische Zeitschrift vol. 8,3 (1966): 147-61. doi: https://doi.org/10.1002/bimj.19660080302
Brock N, Schneider B. Quantitative Methoden bei der pharmakotherapeutischen Bewertung von Arzneimitteln--Auswertung, Planung, Screening. [Quantitative methods of pharmacotherapeutical evaluation of drugs--evaluation, planning, screening]. Biom Z. 1966;8(3):147-61. doi: 10.1002/bimj.19660080302. German. PMID: 5183162.
Copy Download .nbib Format: NLM
Edward Robinson Squibb (1819-1900): advocate of product standards.

Journal of the American Pharmacists Association : JAPhA

Worthen DB.
PMID: 17176693
J Am Pharm Assoc (2003). 2006 Nov-Dec;46(6):754-8. doi: 10.1331/1544-3191.46.6.754.worthen.

No abstract available.

Cite
Worthen DB. Edward Robinson Squibb (1819-1900): advocate of product standards. J Am Pharm Assoc (2003). 2006;46(6):754-8doi: 10.1331/1544-3191.46.6.754.worthen.
Worthen, D. B. (2006). Edward Robinson Squibb (1819-1900): advocate of product standards. Journal of the American Pharmacists Association : JAPhA, 46(6), 754-8. https://doi.org/10.1331/1544-3191.46.6.754.worthen
Worthen, Dennis B. "Edward Robinson Squibb (1819-1900): advocate of product standards." Journal of the American Pharmacists Association : JAPhA vol. 46,6 (2006): 754-8. doi: https://doi.org/10.1331/1544-3191.46.6.754.worthen
Worthen DB. Edward Robinson Squibb (1819-1900): advocate of product standards. J Am Pharm Assoc (2003). 2006 Nov-Dec;46(6):754-8. doi: 10.1331/1544-3191.46.6.754.worthen. PMID: 17176693.
Copy Download .nbib Format: NLM
Study of the amphibite neutralization curves using the pR.

Anales. Asociacion de Quimica y Farmacia del Uruguay

RODRIGUEZ REGULI J.
PMID: 20986665
An Asoc Quim Farm Uruguay. 1945;47(2):139-47.

No abstract available.

Cite
RODRIGUEZ REGULI J. Estudio de las curvas de neutralización de los anfólitos mediante el pR. Study of the amphibite neutralization curves using the pR. An Asoc Quim Farm Uruguay. 1945;47(2):139-47
RODRIGUEZ REGULI, J. (1945). Estudio de las curvas de neutralización de los anfólitos mediante el pR. Study of the amphibite neutralization curves using the pR. Anales. Asociacion de Quimica y Farmacia del Uruguay, 47(2), 139-47.
RODRIGUEZ REGULI, J. "Estudio de las curvas de neutralización de los anfólitos mediante el pR." Study of the amphibite neutralization curves using the pR. Anales. Asociacion de Quimica y Farmacia del Uruguay vol. 47,2 (1945): 139-47.
RODRIGUEZ REGULI J. Estudio de las curvas de neutralización de los anfólitos mediante el pR. Study of the amphibite neutralization curves using the pR. An Asoc Quim Farm Uruguay. 1945;47(2):139-47. Spanish. PMID: 20986665.
Copy Download .nbib Format: NLM
Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?.

Health care law monthly

Dooley K, Sullivan JA.
PMID: 21302589
Health Care Law Mon. 2010 Oct;2010(10):2-8.

No abstract available.

Cite
Dooley K, Sullivan JA. Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?. Health Care Law Mon. 2010;2010(10):2-8
Dooley, K., & Sullivan, J. A. (2010). Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?. Health care law monthly, 2010(10), 2-8.
Dooley, Kathleen, and Sullivan, Julie Ann. "Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?." Health care law monthly vol. 2010,10 (2010): 2-8.
Dooley K, Sullivan JA. Analysis of pharmaceutical product diversion and the gray market: cheaper drugs, but at what cost?. Health Care Law Mon. 2010 Oct;2010(10):2-8. PMID: 21302589.
Copy Download .nbib Format: NLM
[Pharmacological and pharmaceutical foundation of nanodrugs].

Likars'ka sprava

Chekman IS.
PMID: 20614509
Lik Sprava. 2010 Jan-Mar;(1):3-10.

Literary data and results of own investigations about pharmacological and pharmaceutical grounds of nanodrugs are analyzed in the article. Main requirements to nanodrugs are summarized. (1) To have much more expressed effect in comparison with drugs used in a...

Cite
Chekman IS. [Pharmacological and pharmaceutical foundation of nanodrugs]. Lik Sprava. 2010;(1):3-10
Chekman, I. S. (2010). [Pharmacological and pharmaceutical foundation of nanodrugs]. Likars'ka sprava, (1), 3-10.
Chekman, I S. "[Pharmacological and pharmaceutical foundation of nanodrugs]." Likars'ka sprava vol. ,1 (2010): 3-10.
Chekman IS. [Pharmacological and pharmaceutical foundation of nanodrugs]. Lik Sprava. 2010 Jan-Mar;(1):3-10. Ukrainian. PMID: 20614509.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 31 entries